BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr | ₹19 Cr |
What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹19 Cr |
How is Cash Flow from Operating Activities of BETA DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 16.86 | |
| Mar2024 | ₹31 Cr | 32.28 | |
| Mar2023 | ₹23 Cr | -21.08 | |
| Mar2022 | ₹30 Cr | 59.29 | |
| Mar2021 | ₹19 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,831.3 Cr | 1.9% | 12.8% | 50.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.9% |
12.8% |
50.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses